Age-related changes in the pancreas identified by EUS: a prospective evaluation
- PMID: 15758911
- DOI: 10.1016/s0016-5107(04)02758-0
Age-related changes in the pancreas identified by EUS: a prospective evaluation
Abstract
Background: EUS is an important modality for the diagnosis of pancreatic disease. An understanding of normal pancreatic ductal and parenchymal variation in asymptomatic individuals is essential to improve EUS accuracy. The primary aim of this study was to determine age-related pancreatic parenchymal and ductular changes identifiable on EUS in individuals with no history or symptoms of pancreaticobiliary disease. Secondary aims were to define demographic and clinical factors associated with identifiable pancreatic parenchymal and ductular changes, and to determine the main pancreatic-duct diameter and pancreatic-gland width according to age.
Methods: Patients referred for either upper endoscopy or EUS for an indication unrelated to pancreaticobiliary disease were prospectively enrolled. Patients were stratified by age (<40, 40-60, >60 years). Each patient was assessed for the presence of EUS findings for chronic pancreatitis. Logistic regression was used to identify factors associated with an abnormality.
Results: A total of 120 patients (63 men, 57 women; median age, 52 years, interquartile range [IQR] 40-61 years) were prospectively evaluated. At least one parenchymal and/or ductular abnormality was identified in 28% of the patients, with a trend of increasing abnormality with age: <40 years (23%), 40 to 60 years (25%), and >60 years (39%); p = 0.13. No patient had more than 3 abnormal EUS features. Hyperechoic stranding (n = 22) was the most common finding in all age groups. The odds for any abnormality in men (relative to women) was significantly higher (OR 2.9: 95% CI[1.2, 6.8], p = 0.01), with 38% of men and 18% of women having an abnormality. Smoking, low alcohol intake, body mass index, and endoscopic finding were not significantly associated with an abnormal EUS. The overall median pancreatic-gland width and main pancreatic duct diameter were 15 mm (IQR 6-25 mm) and 1.7 mm (IQR 0.9-4.3 mm), respectively.
Conclusions: The frequency of EUS abnormalities in patients without clinical evidence of chronic pancreatitis increases with age, particularly after 60 years of age. The threshold number of EUS criteria for the diagnosis of chronic pancreatitis is variable. However, the typically used standard of 3 or more criteria appears appropriate. A higher number of threshold criteria may be needed in males and to a lesser extent in patients over 40 years of age, which should be related to clinical history and other structural or functional studies. Ductal or parenchymal calculi, ductal narrowing, ductal dilatation, or more than 3 abnormalities appear to be more specific features for the EUS diagnosis of chronic pancreatitis at any age.
Comment in
-
Gender-related changes in the pancreas detected by EUS.Gastrointest Endosc. 2005 Sep;62(3):475. doi: 10.1016/j.gie.2005.05.005. Gastrointest Endosc. 2005. PMID: 16111987 No abstract available.
Similar articles
-
Chronic pancreatitis-like changes detected by endoscopic ultrasound in subjects without signs of pancreatic disease: do these indicate age-related changes, effects of xenobiotics, or early chronic pancreatitis?Pancreatology. 2010;10(5):597-602. doi: 10.1159/000314599. Epub 2010 Oct 29. Pancreatology. 2010. PMID: 20980777
-
Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin.Endoscopy. 1993 Nov;25(9):555-64. doi: 10.1055/s-2007-1010405. Endoscopy. 1993. PMID: 8119204
-
Pancreatic abnormalities detected by endoscopic ultrasound (EUS) in patients without clinical signs of pancreatic disease: any difference between standard and Rosemont classification scoring?Pancreatology. 2014 May-Jun;14(3):227-30. doi: 10.1016/j.pan.2014.03.002. Epub 2014 Mar 28. Pancreatology. 2014. PMID: 24854620
-
Endoscopic Ultrasound for Routine Assessment in Idiopathic Acute Pancreatitis.J Gastrointest Surg. 2019 Aug;23(8):1694-1700. doi: 10.1007/s11605-019-04272-3. Epub 2019 Jun 13. J Gastrointest Surg. 2019. PMID: 31197695
-
Endoscopic ultrasound and pancreas divisum.JOP. 2012 May 10;13(3):252-7. JOP. 2012. PMID: 22572127 Review.
Cited by
-
EUS pancreatic function testing and dynamic pancreatic duct evaluation for the diagnosis of exocrine pancreatic insufficiency and chronic pancreatitis.Gastrointest Endosc. 2021 Feb;93(2):444-453. doi: 10.1016/j.gie.2020.06.029. Epub 2020 Jun 17. Gastrointest Endosc. 2021. PMID: 32562609 Free PMC article. Clinical Trial.
-
EUS and related technologies for the diagnosis and treatment of pancreatic disease: research gaps and opportunities-Summary of a National Institute of Diabetes and Digestive and Kidney Diseases workshop.Gastrointest Endosc. 2017 Nov;86(5):768-778. doi: 10.1016/j.gie.2017.08.006. Epub 2017 Sep 20. Gastrointest Endosc. 2017. PMID: 28941651 Free PMC article. Review.
-
The role of EUS in the diagnosis of early chronic pancreatitis.Endosc Ultrasound. 2024 Jul-Aug;13(4):232-238. doi: 10.1097/eus.0000000000000077. Epub 2024 Aug 21. Endosc Ultrasound. 2024. PMID: 39318759 Free PMC article.
-
Endoscopic ultrasonography for evaluating patients with recurrent pancreatitis.World J Gastroenterol. 2008 Feb 21;14(7):1016-22. doi: 10.3748/wjg.14.1016. World J Gastroenterol. 2008. PMID: 18286681 Free PMC article. Review.
-
Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment.Dig Dis Sci. 2017 Jul;62(7):1702-1712. doi: 10.1007/s10620-017-4602-2. Epub 2017 May 13. Dig Dis Sci. 2017. PMID: 28501969 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources